Drug
Bcx4430
Bcx4430: highest development phase Phase 1, developed by BioCryst Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- BioCryst Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| BCX4430 NCT02319772 | Phase 1 | Filovirus Infections |
Latest
No recent events.
Follow Bcx4430 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.